0001179110-20-010225.txt : 20201005
0001179110-20-010225.hdr.sgml : 20201005
20201005161625
ACCESSION NUMBER: 0001179110-20-010225
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201001
FILED AS OF DATE: 20201005
DATE AS OF CHANGE: 20201005
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Namouni Fouad
CENTRAL INDEX KEY: 0001815851
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37359
FILM NUMBER: 201223759
MAIL ADDRESS:
STREET 1: 535 BOYLSTON ST., 2ND FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Blueprint Medicines Corp
CENTRAL INDEX KEY: 0001597264
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 45 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-374-7580
MAIL ADDRESS:
STREET 1: 45 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
edgar.xml
FORM 4 -
X0306
4
2020-10-01
0
0001597264
Blueprint Medicines Corp
BPMC
0001815851
Namouni Fouad
C/O BLUEPRINT MEDICINES CORPORATION
45 SIDNEY STREET
CAMBRIDGE
MA
02139
0
1
0
0
President, R & D
Common Stock
2020-10-01
4
A
0
32500
0
A
32500
D
Stock Option (Right to Buy)
93.93
2020-10-01
4
A
0
65000
0
A
2030-10-01
Common Stock
65000
65000
D
The reported transaction involved the Reporting Person's receipt of a grant of 32,500 restricted stock units under the Issuer's 2020 Inducement Plan.
This option vests with respect to 25% of the shares underlying the option on October 1, 2021 and as to an additional 1/48th of the shares underlying the option each month thereafter.
/s/ Christopher Frankenfield, Attorney-in-Fact
2020-10-05